Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
Department of Health and Human Services
This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations (fentanyl and xylazine). This NOFO will also support research on the persistent and/or delayed pathophysiological effects after acute exposure to such agents.
Funding
Award size
$100K – $1M
Award ceiling
300000
Type
Grant
Dates
Deadline
Later
Posted
11/20/2024
Closes
2027-11-18
Eligibility
Eligibility
County governmentsIndependent school districtsPublic and State controlled institutions of higher educationFor profit organizations other than small businessesSpecial district governmentsCity or township governmentsPublic housing authorities/Indian housing authoritiesState governmentsNative American tribal governments (Federally recognized)Private institutions of higher educationOthers (see text field entitled "Additional Information on Eligibility" for clarification)Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationSmall businessesNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationNative American tribal organizations (other than Federally recognized tribal governments)
Program
Funding area
Education - EDHealth - HL
Opportunity #
RFA-DA-26-034
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov